Medical Editor: John P. Cunha, DO, FACOEP
Elocon (mometasone furoate) Ointment is a corticosteroid prescribed for the treatment of skin conditions such as atopic dermatitis, allergic dermatitis, contact dermatitis, lupus, genital itching, plaque psoriasis, anal itching, psoriasis of the scalp, and seborrheic dermatitis. Common side effects of Elocon Ointment include skin rash, itching, burning, redness, dryness, thinning or softening of your skin, skin rash or irritation around your mouth, swollen hair follicles, spider veins, numbness or tingling, changes in color of treated skin, blisters, pimples, crusting of treated skin, stretch marks, blurred vision, seeing halos around lights, and mood changes.
Each gram of Elocon contains 1 mg mometasone furoate. Apply a thin film of Elocon ointment to the affected skin area once daily. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary by a health care professional. Elocon Ointment may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant during treatment with Elocon Ointment; it may harm a fetus. Caution should be exercised when Elocon ointment is administered to a woman who is breastfeeding. Safety and efficacy of Elocon ointment have not been adequately established in pediatric patients below 2 years of age.
Our Elocon (mometasone furoate) Ointment Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing mometasone topical through your skin, such as:
- blurred vision, or seeing halos around lights;
- mood changes;
- sleep problems (insomnia);
- weight gain, puffiness in your face; or
- muscle weakness, feeling tired.
Less serious side effects may include:
- mild skin rash, itching, burning, redness, or dryness;
- thinning or softening of your skin;
- skin rash or irritation around your mouth;
- swollen hair follicles;
- spider veins;
- numbness or tingling;
- changes in color of treated skin;
- blisters, pimples, or crusting of treated skin; or
- stretch marks.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Elocon Ointment (Mometasone Furoate Ointment)
In controlled clinical studies involving 812 patients, the incidence of adverse reactions associated with the use of ELOCON Ointment (mometasone furoate ointment) was 4.8%. Reported reactions included burning, pruritus, skin atrophy, tingling/stinging, and furunculosis. Reports of rosacea associated with the use of ELOCON Ointment (mometasone furoate ointment) have been received. In controlled clinical studies (n=74) involving pediatric patients 2 to 12 years of age, the incidence of adverse experiences associated with the use of ELOCON Cream is approximately 7%. Reported reactions included stinging, pruritus, and furunculosis.
The following adverse reactions were reported to be possibly or probably related to treatment with ELOCON Ointment (mometasone furoate ointment) during a clinical study, in 5% of 63 pediatric patients 6 months to 2 years of age: decreased glucocorticoid levels, 1; an unspecified skin disorder, 1; and a bacterial skin infection, 1. The following signs of skin atrophy were also observed among 63 patients treated with ELOCON Ointment (mometasone furoate ointment) in a clinical study: shininess 4, telangiectasia 1, loss of elasticity 4, loss of normal skin markings 4, thinness 1. Striae and bruising were not observed in this study.
The following additional local adverse reactions have been reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae, and miliaria.
Read the entire FDA prescribing information for Elocon Ointment (Mometasone Furoate Ointment)
© Elocon Ointment Patient Information is supplied by Cerner Multum, Inc. and Elocon Ointment Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.